Cormorant Asset Management, LP - RA PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Cormorant Asset Management, LP ownership history of RA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$13,873,000
+98.4%
295,6000.0%0.55%
+30.0%
Q3 2019$6,991,000
-33.6%
295,600
-15.5%
0.43%
-29.6%
Q2 2019$10,525,000
+17.5%
350,000
-12.5%
0.60%
-0.2%
Q1 2019$8,960,000
+11.6%
400,000
-9.3%
0.61%
-7.1%
Q4 2018$8,026,000441,0000.65%
Other shareholders
RA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
NEA Management Company, LLC 6,138,797$294,724,00015.40%
RA Capital Management 4,858,260$233,245,0007.37%
HAVENS ADVISORS LLC 143,266$6,878,0006.70%
BARDIN HILL MANAGEMENT PARTNERS LP 609,614$29,267,0006.40%
OMNI PARTNERS LLP 1,052,744$50,542,0004.45%
HBK INVESTMENTS L P 2,004,042$96,214,0004.03%
ALPINE ASSOCIATES MANAGEMENT INC. 2,005,600$96,289,0003.83%
Versor Investments LP 1,108,845$53,236,0003.53%
OXFORD ASSET MANAGEMENT LLP 461,016$22,133,0003.12%
HighVista Strategies LLC 63,222$3,035,0002.81%
View complete list of RA PHARMACEUTICALS INC shareholders